AN2 Therapeutics, Inc. (ANTX)
5.74
-0.24
(-4.01%)
USD |
NASDAQ |
Sep 09, 12:39
AN2 Therapeutics Price to Book Value : 2.745 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.860 |
| September 04, 2026 | 2.817 |
| September 03, 2026 | 2.846 |
| September 02, 2026 | 2.846 |
| September 01, 2026 | 2.621 |
| August 31, 2026 | 2.654 |
| August 28, 2026 | 2.669 |
| August 27, 2026 | 2.745 |
| August 26, 2026 | 2.645 |
| August 25, 2026 | 2.707 |
| August 24, 2026 | 2.692 |
| August 21, 2026 | 2.779 |
| August 20, 2026 | 2.769 |
| August 19, 2026 | 2.850 |
| August 18, 2026 | 2.855 |
| August 17, 2026 | 2.740 |
| August 14, 2026 | 2.865 |
| August 13, 2026 | 2.860 |
| August 12, 2026 | 3.003 |
| August 11, 2026 | 2.807 |
| August 10, 2026 | 2.826 |
| August 07, 2026 | 2.836 |
| August 06, 2026 | 2.908 |
| August 05, 2026 | 2.793 |
| August 04, 2026 | 2.841 |
| Date | Value |
|---|---|
| August 03, 2026 | 2.669 |
| July 31, 2026 | 2.559 |
| July 30, 2026 | 2.549 |
| July 29, 2026 | 2.401 |
| July 28, 2026 | 2.248 |
| July 27, 2026 | 2.358 |
| July 24, 2026 | 2.353 |
| July 23, 2026 | 2.353 |
| July 22, 2026 | 2.339 |
| July 21, 2026 | 2.391 |
| July 20, 2026 | 2.296 |
| July 17, 2026 | 2.238 |
| July 16, 2026 | 2.233 |
| July 15, 2026 | 2.233 |
| July 14, 2026 | 2.276 |
| July 13, 2026 | 2.176 |
| July 10, 2026 | 2.152 |
| July 09, 2026 | 2.214 |
| July 08, 2026 | 2.109 |
| July 07, 2026 | 2.056 |
| July 06, 2026 | 2.109 |
| July 02, 2026 | 2.114 |
| July 01, 2026 | 2.248 |
| June 30, 2026 | 2.315 |
| June 29, 2026 | 2.214 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 16.25 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 1.027 |
| Fulcrum Therapeutics, Inc. | 0.9318 |
Price to Book Value Related Metrics
| Price | 5.74 |
| Earnings Yield | -18.70% |
| Market Cap | 208.41M |